Sarah Cannon
January 06, 2015

For Sarah Cannon, 2014 was a year of significant achievements — all supporting its goal of redefining cancer care around the world through clinical excellence and cutting-edge research. In the past 12 months, Sarah Cannon, the global cancer institute of HCA, and Sarah Cancer Research Institute (SCRI), Sarah Cannon’s research arm, have continued to be at the forefront of drug research and excellent patient care, by sharing knowledge and findings in presentations at international conferences and in medical journals. Find out more about our momentous year, which resulted in more than one dozen new cancer drug approvals and hundreds of abstracts and publications, in our blog here.